NYSE Euronext Inc

NYSE Euronext — Q4 2012 Earnings Presentation

23 slides from NYSE Euronext's earnings presentation, Feb 5, 2013

  1. Slide 1: Fourth Quarter & FY 2012 Earnings Presentation

    NYSE EURONEXT FOURTH QUARTER & FY 2012 EARNINGS PRESENTATION February 5, 2013

  2. Slide 2: Legal Disclaimers

    LEGAL DISCLAIMERS Non-GAAP Financial Measures To supplement NYSE Euronext’s consolidated financial statements prepared in accordance with GAAP and to better reflect period-over-period comparisons, NYSE Euronext uses non-GAAP financial measures of performance, financial position, or cash flows that e

  3. Slide 3: Legal Disclaimers

    LEGAL DISCLAIMERS IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND WHERE TO FIND IT This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval. In connection with the proposed transaction, ICE has fi

  4. Slide 4: 4Q12 Highlights

    4Q12 HIGHLIGHTS  Diluted EPS 2 of $0.43 vs. $0.50  $562 million in net revenues 3, down 11% including $4 million negative FX impact Our Results 1  Other operating expenses 4 of $392 million, down 9% on constant dollar / portfolio basis  Operating income 4 of $170 million, down 20%  Debt / EBITD

  5. Slide 5: We Are Executing Against Our Plans

    WE ARE EXECUTING AGAINST OUR PLANS Unlocking the Power of the Community Access to GROWTH Operating Leverage and Flexibility for Opportunities EFFICIENCY Strategic CAPITAL Deployment IN PROGRESS IN PROGRESS IN PROGRESS  Strong listings momentum  Establish new derivatives clearing  Review of invest

  6. Slide 6: New Derivatives Product Update

    NEW DERIVATIVES PRODUCT UPDATE LIFFE EU LIFFE U.S.  Launched 4 Year Mid-Curve Options on Euribor & Short Sterling ADV Mini MSCI Index Futures 25,000 futures 160 Euribor Mid-curve Options (ADV) Other Exchanges & Liffe U.S. ADV All ADV on Liffe U.S. K lots 140 25 20,000 120 23 Emerging Markets ADV 4y

  7. Slide 7: Equities and Equity Derivatives Update

    EQUITIES AND EQUITY DERIVATIVES UPDATE U.S. Options U.S. Options ADV & Market Share Mkt Share 6 30.0% ADV in MM’s Combined market share  In 2012 retained the #1 or #2 5 25.0% position by market share 4 20.0%  January 2013, set a new record NYSE ARCA 3 15.0% combined market share of 29.3% 2 10.0% 

  8. Slide 8: Clearing Agreement with ICE Clear

    CLEARING AGREEMENT WITH ICE CLEAR Key Trading Licenses Trading LIFFE Trading Platform / LIFFE ICE CLEAR Market Derivatives External providers Trade and Position Mgt Clearing ICE Clear Europe License SPAN Exposure Calc Clearing Risk Oversight, Stress Testing, Back Testing, Risk Mgt Settlement & Liqui

  9. Slide 9: Momentum in Listings

    MOMENTUM IN LISTINGS Global 2012 IPO Capital Raised ($B)  NYSE Euronext was $36.9 Facebook – $16.0B ranked #1 in IPOs $23.4 globally for the 2nd 120 $12.4 consecutive year 1 $10.2 74 25 120 120 $7.3 11 $7.3 $6.4  NYSE Euronext listed 35 15 44 41 5143 NYSE Euronext Nasdaq OMX Tokyo Shenzhen Kuala L

  10. Slide 10: NYSE Technologies Strategic Update

    NYSE TECHNOLOGIES STRATEGIC UPDATE Market Solutions Transactions Colocation FIX Enterprise Services Software Liquidity DART Solutions SFTI Partner Management Connectivity Products FIX Services Middleware Software Content Infrastructure SFTI Cloud Services Consolidated Solutions Solutions Feed Servic

  11. Slide 11: Transaction Update

    TRANSACTION UPDATE Strong industrial logic based on long-term growth opportunities, synergies, focused business model and global franchise  Regulatory reform continues to drive migration of asset classes to exchange traded and cleared environment  Demand for enhanced transparency, cleared products

  12. Slide 12: GAAP 4Q12 Financial Results

    GAAP 4Q12 FINANCIAL RESULTS ($ in millions, except per share data) 4Q12 3Q12 4Q11 Total Revenue¹ $909 $902 $1,054 Operating Income $97 $153 $124 Net Income $28 $108 $110 Diluted EPS $0.12 $0.44 $0.43 Pre-tax Adjustments 4Q12 3Q12 4Q11 Merger & Other Exit Costs ($24) ($18) ($46) Clearing Transition (

  13. Slide 13: Non-GAAP 4Q12 Financial Results

    NON-GAAP 4Q12 FINANCIAL RESULTS ($ in millions, except per share data) % ∆ 4Q12 Full-Year % ∆ FY12 4Q12 3Q12 4Q11 vs. 4Q11 2012 2011 vs. FY11 Total Revenue¹ $909 $902 $1,054 (14%) $3,749 $4,552 (18%) Transaction-based Expenses² $347 $343 $426 (19%) $1,425 $1,880 (24%) Total Revenues, Less Transactio

  14. Slide 14: F/X Impact by Segment

    F/X IMPACT BY SEGMENT ($ in millions) Select Financial Highlights $ Variance Attribution 4Q12 4Q11 Total FX Specific Operational % Operational 1 Net Revenue $562 $628 ($66) ($4) ($62) (10%) 2 Operating Expenses ($392) ($416) $24 $1 $23 (6%) 2 Operating Income $170 $212 ($42) ($3) ($39) (18%) F/X Imp

  15. Slide 15: Derivatives Highlights

    DERIVATIVES HIGHLIGHTS ($ in millions) % ∆ 4Q12 % ∆ FY12 4Q12 3Q12 4Q11 vs. 4Q11 FY2012 FY2011 vs. FY11 Total Revenue $221 $220 $244 (9%) $910 $1,135 (20%) Net Revenue¹ $160 $164 $186 (14%) $682 $861 (21%) % of total 28% 29% 30% 29% 32% Other Operating Expenses² $97 $96 $100 (3%) $387 $388 (0%) Oper

  16. Slide 16: Derivatives Trading Volumes and Capture

    DERIVATIVES TRADING VOLUMES AND CAPTURE ($ in millions) European Derivatives ADV Contracts in thousands 4Q11 1Q12 2Q12 3Q12 4Q12 6,000 Total Revenue $ 154 $ 147 $ 161 $ 143 $ 133 4,654 3,615 Liquidity Payments (32) (33) (37) (34) (32) 4,000 3,332 3,383 3,534 1,743 868 673 829 Routing and Clearing -

  17. Slide 17: Cash Trading & Listings Highlights

    CASH TRADING & LISTINGS HIGHLIGHTS ($ in millions) % ∆ 4Q12 % ∆ FY12 4Q12 3Q12 4Q11 vs. 4Q11 FY2012 FY2011 vs. FY11 Total Revenue¹ $568 $569 $683 (17%) $2,365 $2,929 (19%) Net Revenue² $282 $282 $315 (10%) $1,168 $1,323 (12%) % of total 50% 50% 50% 50% 50% Other Operating Expenses3 $182 $178 $190 (4

  18. Slide 18: Cash Trading Volumes and Capture

    CASH TRADING VOLUMES AND CAPTURE ($ in millions) European Cash ADV Trades in thousands 4Q11 1Q12 2Q12 3Q12 4Q12 2,000 1,709 Total Revenue $ 59 $ 59 $ 55 $ 46 $ 44 1,585 1,583 1,500 1,318 Liquidity Payments - - - - - 1,179 Routing and Clearing - - - - - 1,000 Net Revenue $ 59 $ 59 $ 55 $ 46 $ 44 500

  19. Slide 19: Info. Svcs. & Tech. Solutions Highlights

    INFO. SVCS. & TECH. SOLUTIONS HIGHLIGHTS ($ in millions) % ∆ 4Q12 % ∆ FY12 4Q12 3Q12 4Q11 vs. 4Q11 FY2012 FY2011 vs. FY11 Total Revenue $120 $113 $127 (6%) $473 $490 (3%) % of total 21% 20% 20% 20% 18% Other Operating Expenses1 $85 $90 $96 (11%) $360 $364 (1%) Operating Income1 $35 $23 $31 13% $113

  20. Slide 20: 2012 Operating Expense Reconciliation & 2013 Guidance

    2012 OPERATING EXPENSE RECONCILIATION & 2013 GUIDANCE ($ in millions) Project 14 Base FY Guidance 2013 Guidance Other Operating Expenses¹ 2011 2012 2013 vs. 2012 Non-GAAP Expenses ($1,666) ($1,581) ($1,525) $56 2 P14 Currency Rates Adjustment - ($14) ($15) ($1) Non-GAAP Expenses Rebased ($1,666) ($1

  21. Slide 21: Other Guidance

    OTHER ($ in millions) 2013 GUIDANCE Costs  Clearing agreement with ICE Clear to begin July 1, 2013 for 5 years  Cost savings from refinancing expected to be $15 million in 2013 and $24 million in 2014 Capital  MCX and partial LCH stake sales expected in 1st half 2013  CAPEX is expected to be ~$1

  22. Slide 22: Strong Balance Sheet & Liquidity

    STRONG BALANCE SHEET & LIQUIDITY ($ in billions) Cash & Investment Securities $0.4 Total Debt $2.5 Key ► 2.0% $850m notes due Oct 2017 $0.9 ► 5.375% €1bn notes due June 2015 $1.2 Balance Sheet ► 4.8% $750m notes due June 2013 $0.4 ► Commercial paper in $ and € $0.0 Indicators as of 12/31/2012 Net De

  23. Slide 23: Slide 23

NYSE Euronext — Q4 2012 Earnings Presentation on 6ix